- Home
- PCRX vs ACIC Comparison
PCRX vs ACIC Comparison
Compare PCRX & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- ACIC
- Stock Information
- Founded
- PCRX 2006
- ACIC 1999
- Country
- PCRX United States
- ACIC United States
- Employees
- PCRX N/A
- ACIC N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- ACIC Property-Casualty Insurers
- Sector
- PCRX Health Care
- ACIC Finance
- Exchange
- PCRX Nasdaq
- ACIC Nasdaq
- Market Cap
- PCRX 1.2B
- ACIC 546.2M
- IPO Year
- PCRX 2011
- ACIC N/A
- Fundamental
- Price
- PCRX $22.33
- ACIC $12.13
- Analyst Decision
- PCRX Buy
- ACIC Buy
- Analyst Count
- PCRX 5
- ACIC 1
- Target Price
- PCRX $32.40
- ACIC $16.00
- AVG Volume (30 Days)
- PCRX 494.3K
- ACIC 159.0K
- Earning Date
- PCRX 11-05-2025
- ACIC 11-05-2025
- Dividend Yield
- PCRX N/A
- ACIC 4.26%
- EPS Growth
- PCRX N/A
- ACIC 14.01
- EPS
- PCRX N/A
- ACIC 1.63
- Revenue
- PCRX $705,848,000.00
- ACIC $320,072,000.00
- Revenue This Year
- PCRX $7.36
- ACIC $4.91
- Revenue Next Year
- PCRX $10.07
- ACIC $4.16
- P/E Ratio
- PCRX N/A
- ACIC $7.19
- Revenue Growth
- PCRX 2.25
- ACIC 33.90
- 52 Week Low
- PCRX $15.92
- ACIC $9.97
- 52 Week High
- PCRX $27.64
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- PCRX 25.66
- ACIC 61.54
- Support Level
- PCRX $24.31
- ACIC $11.67
- Resistance Level
- PCRX $26.05
- ACIC $12.41
- Average True Range (ATR)
- PCRX 0.77
- ACIC 0.31
- MACD
- PCRX -0.36
- ACIC 0.04
- Stochastic Oscillator
- PCRX 7.54
- ACIC 78.91
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.